Time from sudden sensory neural hearing loss to treatment as a prognostic factor

The widely accepted treatment for sudden sensorineural hearing loss (SSNHL) is corticosteroid treatment (oral or intratympanic). The main goal of this work is to define the significance of the time between symptom onset and treatment initiation, as well as other prognostic factors, for hearing impro...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in neurology 2023-04, Vol.14, p.1158955-1158955
Main Authors: Chen, Itay, Eligal, Shalom, Menahem, Ori, Salem, Riki, Sichel, Jean-Yves, Perez, Ronen, Shaul, Chanan
Format: Article
Language:English
Subjects:
audiogram
corticosteorids
discrimination
hearing loss
intratymapnic injection
Neurology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The widely accepted treatment for sudden sensorineural hearing loss (SSNHL) is corticosteroid treatment (oral or intratympanic). The main goal of this work is to define the significance of the time between symptom onset and treatment initiation, as well as other prognostic factors, for hearing improvement. This retrospective study included 666 patients treated for SSNHL. Demographic data, audiometry, treatment method, time since symptom onset, and associated symptoms were recorded for each patient. The patients were divided into five groups according to the treatment initiation time-half a week, one week, 2 weeks, 3 weeks, or 4 weeks and over-after symptom onset. The degree of improvement was assessed by comparing the audiometry at the beginning and the end of the treatment. The average period of hearing loss from symptom onset to treatment initiation was 10.8 days. Significant differences were found between the groups of half a week, one week, and 2 weeks and the groups of 3 weeks and 4 weeks and over (each separately,
ISSN:1664-2295
1664-2295
DOI:10.3389/fneur.2023.1158955